Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.
Duffy, B.C., Liu, S., Martin, G.S., Wang, R., Hsia, M.M., Zhao, H., Guo, C., Ellis, M., Quinn, J.F., Kharenko, O.A., Norek, K., Gesner, E.M., Young, P.R., McLure, K.G., Wagner, G.S., Lakshminarasimhan, D., White, A., Suto, R.K., Hansen, H.C., Kitchen, D.B.(2015) Bioorg Med Chem Lett 25: 2818-2823
- PubMed: 26022843 
- DOI: 10.1016/j.bmcl.2015.04.107
- Primary Citation of Related Structures:  
4YH3, 4YH4 - PubMed Abstract: 
Bromodomains are key transcriptional regulators that are thought to be druggable epigenetic targets for cancer, inflammation, diabetes and cardiovascular therapeutics. Of particular importance is the first of two bromodomains in bromodomain containing 4 protein (BRD4(1)) ...